Renate Pichler

Innsbruck Medical University — Austria

Medicine · Health Sciences

31h-index3.8kcitations314works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(118), Urinary and Genital Oncology Studies(68), Cancer Immunotherapy and Biomarkers(54), Testicular diseases and treatments(40), Urological Disorders and Treatments(40)

Publications312 total

Cardiovascular disease and risk management in patients with nephrotic syndrome
Kidney Research and Clinical Practice·2025Open Access
Interplay of IL‐6, GDF‐15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival
Journal of Cachexia Sarcopenia and Muscle·2025· 1 citedOpen Access
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study
Clinical & Experimental Metastasis·2025
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study
Cancer Immunology Immunotherapy·2025Open Access
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
World Journal of Urology·2025· 1 cited
Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis
International Journal of Cancer·2025· 1 citedOpen Access
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
The Lancet·2025· 20 cited
Temporal trends and clinical determinants of urinary diversion after radical cystectomy
British Journal of Urology·2025· 2 cited
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data
Urologic Oncology Seminars and Original Investigations·2025Open Access
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells
Translational Oncology·2025· 3 citedOpen Access
3115eP Real-world clinical outcomes of avelumab (A), pembrolizumab (P) or enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC) with squamous differentiation (UCSD): Results from the Aron-2 study
Annals of Oncology·2025
2672eP Real-world evidences on adjuvant pembrolizumab for renal cell carcinoma: Results from the Multicenter ARON-1 study
Annals of Oncology·2025
Defining statistical cure in patients with T1 high‐grade non‐muscle‐invasive bladder carcinoma treated with BCG immunotherapy
British Journal of Urology·2025
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma
Clinical & Experimental Metastasis·2025· 1 citedOpen Access
Acute Kidney Injury Causes Chronic Kidney Disease Progression after Partial Nephrectomy: A Retrospective Study Identifying Patients at Risk
Urologia Internationalis·2025
Local Therapy of the Primary Tumor: An Option for Metastatic Urothelial Carcinoma in the Era of Novel Combination Therapies?
European Urology Open Science·2025Open Access
Traditional and next-generation bacillus Calmette-Guérin based treatment strategies for bacillus Calmette-Guérin unresponsive non-muscle-invasive bladder cancer in the era of emerging therapies
Current Opinion in Urology·2025· 2 cited
Impact of timing of computed tomography staging and patient factors on the detection of ‘true’ <scp>cN</scp>+ bladder cancer
British Journal of Urology·2025Open Access
FGFR1/3 Signaling as an Achilles’ Heel of Phenotypic Diversity in Urothelial Carcinoma
European Urology Oncology·2025· 1 citedOpen Access
Re: Cariss E. Chu, Ziyu Chen, Karissa Whiting, et al. Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma. Eur Urol. 2025;88:472–481
European Urology·2025
page 1 of 16Next →

Frequent Co-authors

Wolfgang Horninger(19), Isabel Heidegger(18), Josef Fritz(9), Friedrich Aigner(9), Martin Pichler(8), Helmut Klocker(8), Andreas Pircher(7), Jasmin Bektić(7), Nicolai Leonhartsberger(6), Axel Heidenreich(5), Andrea Brunner(5), Peter Rehder(5), Gennadi Tulchiner(5), Martin Thurnher(5), Hannes Steiner(5), Eberhard Steiner(5), Viktor Skradski(5), Klaus‐Peter Dieckmann(4), Friedemann Zengerling(4), Wolfgang Loidl(4)